Changing patterns of neurological mortality in the 10 major developed countries - 1979-2010

Public Health

Volumn 127, Issue 4, 2013, Pages 357-368

  Pritchard, C ^a   Mayers, A ^a   Baldwin, D ^b  

^a BOURNEMOUTH UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Age; Gender; International comparison; Neurological deaths

Indexed keywords

AGE; GENDER; HEALTH RISK; INTERNATIONAL COMPARISON; MORTALITY; NERVOUS SYSTEM DISORDER; NEUROLOGY; PUBLIC HEALTH;

ADULT; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; AUSTRALIA; CANADA; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEVELOPED COUNTRY; DISEASE SURVEILLANCE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; ITALY; MALE; MORBIDITY; MORTALITY; MOTOR NEURON DISEASE; NETHERLANDS; NEUROLOGIC DISEASE; PARKINSON DISEASE; PUBLIC HEALTH PROBLEM; SEX DIFFERENCE; UNITED KINGDOM; UNITED STATES;

AGE DISTRIBUTION; AGED; AUSTRALIA; CANADA; DEVELOPED COUNTRIES; EUROPE; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MORTALITY; NERVOUS SYSTEM DISEASES; SEX DISTRIBUTION; UNITED STATES;

AUSTRALIA; CANADA; ENGLAND; ITALY; NETHERLANDS; SPAIN; UNITED KINGDOM; UNITED STATES; WALES;

EID: 84877016234     PISSN: 00333506     EISSN: 14765616     Source Type: Journal    
DOI: 10.1016/j.puhe.2012.12.018     Document Type: Article

References (40)

1. Day T.G., Scott M., Perring R., Doyle P. Motor neuron disease mortality in Great Britain continues to rise: examination of mortality rates 1975-2004. Amyotrophic Lateral Scler 2007, 8:337-342.
2. WHO International classification of diseases 1992, World Health Organisation, Geneva. 10th edn.
3. WHO WHO mortality database 2012, http://apps.who.int/healthinfo/statstics/mortal.
4. World Health Organization Statistical annual 2008, World Health Organization, Geneva, Switzerland. http://www.who.int/whosis/mort/table1.process.cfm.
5. Bergen D.C., Silberberg D. Nervous system disorders: a global epidemic. Arch Neurol 2002, 59:1194-1196.
6. Chang P.A., Wu Y.J. Motor neurone disease and neuro-toxic substances: a possible link?. Chem Biol Interact 2009, 180:127-130.
7. Lunke S., El-Osta A. The emerging role of epigenetic modifications and chromatin remodelling in spinal muscular atrophy. J Neurochem 2009, 109:1557-1569.
8. Diekstra F.P., Beleza-Meircles A., Leigh N.P., Shaw C.E., Al-Chalabi A. Interaction between PONI and population density in amyotrophic lateral sclerosis. Neuroreport 2009, 20:186-190.
9. Scott K.M., Abhinav K., Wijesekera L., Ganesalingam J., Goldstein L., Janssen A., Dogherty A., Willey E., Stanton B., Turner M., Ampnog M., Sakel M., Al-Chalabi A. The association between ALS and population density: a population based study. Amyotrophic Lateral Scler 2010, 11:435-438.
10. Pritchard C., Evans B.T. Population density and cancer mortality by gender and age in England and Wales and the Western world 1963-1993. Public Health 1997, 111:215-220.
11. Cima V., Logroscino G., D'Ascenzo C., Palmieri A., Vlpe M., Soraru G. Epidemiology of ALS in Padova district, Italy from 1992-2005. Eur J Neurol 2009, 16:920-924.
12. Murphy M., Quinn S., Young J., Parkin P., Taylor B. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. J Neurol 2008, 7:1889-1895.
13. Woodburn K.J., Johnstone E.C. Early-onset dementia in Lothian Scotland: an analysis of clinical features and patterns of decline. Health Bull 1999, 57:384-392.
14. Kelley B.J., Boeve B.F., Josephs K.A. Young-onset dementia: demographic and aetiological characteristics of 235 patients. Arch Neurol 2008, 65:1502-1508.
15. Mercy L., Hodges R.J., Dawson K., Baker R.A., Brayne C. Incidence of early onset dementia in Cambridgeshire, United Kingdom. Neurology 2008, 71:1496-1499.
16. Sabatelli M. Natural history of young-adult amyotrophic lateral sclerosis. Neurology 2008, 71:872-873.
17. Pritchard C., Baldwin D.S., Mayers A. Changing patterns of adult [45-74 years] neurological deaths in the major Western world countries 1979-97. Public Health 2004, 116:1-16.
18. Gladen B.C., Rogen W.J. On graphing rate ratios. Am J Epidemiol 1983, 118:905-908.
19. US. Bureau of Statistics Statistical abstract of the United States 2010, http://www.census.gov/prod/www.stastical-abstract.
20. Pritchard C., Wallace M.S. Comparing the USA, UK and 17 Western countries efficiency and effectiveness in reducing mortality. J R S Med Short 2011, 2:60. 1-10.
21. Pritchard C., Hickish T. Comparing cancer mortality and GDP health expenditure in England & Wales with other major developed countries from 1979-2006. Br J Cancer 2011, 105. advanced pub BJC Open 1-7. http://www.bjc.com.
22. Forbes R.B., Colville S., Parratt J., Swingler R.J. The incidence of motor neuron disease in Scotland. J Neurol 2007, 254:866-869.
23. Marin B., Couratier P., Perux P.M., Logroscino G. Can mortality data be used to estimate amyotrophic lateral sclerosis incidence?. Neuroepidemiology 2011, 36:29-38.
24. Goldacre M.J., Duncan M., Griffith M., Turner M.R. Trends in death certification for Multiple sclerosis, motor neurone disease, Parkinson's disease and epilepsy in English populations 1979-2006. J Neurol 2010, 257:706-715.
25. CJD Surveillence Unit CJD figures 2010, http://www.cjd.ac.uk/figures.htm.
26. ONS Annual mortality statistics England & Wales 2006 2010, Office of National Statistics, CHECK. http://www.ons.mortality/stats.
27. Alonso A., Logroscino G., Jlick SS, Hernan M.A. Incidence and lifetime risk of motor neurone disease in the United Kingdom: a population based study. Eur J Neurol 2009, 16:745-751.
28. Gordon P.H., Artaud F., Aouba A., Laurent F., Meininger V., Elbaz A. Changing mortality for motor neuron disease in France (1968-2007): an age-period cohort analysis. Eur J Epidemiol 2011, 26:729-737.
29. Appleby B.S., Appleby K.K., Crain B.J., Onyike C.U., Wallin M.T., Rabins P.V. Characteristics of established and proposed sporadic Creutzfeldt-Jacob disease variants. Arch Neurol 2009, 66:208-215.
30. Fang F., Valdimarsdottir U., Bellocco R., Ronnevi L.O., Sparen P., Ye W. Amyotrophic lateral sclerosis in Sweden 1991-2005. Arch Neurol 2009, 66:505-509.
31. Alonso V., Villaverde-Hueso A., Hens M.J., Morales-Piga A., Abaitua I., de la Paz M.P. Increase in motor neuron disease mortality in Spain: temporal and geographical analysis (1990-2005). Amyotroph Lateral Scler 2011, 12:192-198.
32. Riggs JE, Schochet SS Jr. Rising mortality due to Parkinson's disease & ALS: a manifestation of the competitive nature of human mortality. J Clin Epidemiol;45:1007-12.
33. Chio A., Magnani C., Schiffer D. Gompertzian analysis of ALS mortality in Italy 1957-1987: application to birth cohorts. Neuroepidemiology 1995, 14:269-277. 1992.
34. Pritchard C., Williams R. Poverty and child (0-14 years) mortality in the USA and other Western countries as an indicator of "how well a country meets the needs of its children" (UNICEF). Int J Adolesc Med Health 2011, 23(3):251-255.
35. Retsky M.W., Swartzendruber D.E., Bame P.D., Wardwell R.H. Computer model challenges breast cancer treatment strategy. Cancer Invest 1994, 12:559-567.
36. Johnansen C. Electromagnetic fields and health effects - epidemiological studies of cancer, diseases of the central nervous system and arrhythmia-related heart disease. Scand J Work Environ Health 2004, 30(Suppl. 1):1-80.
37. Callaghan B., Feldman D., Gruis K., Feldman E. The association of exposure to lead, mercury and selenium and the development of amyotrophic lateral sclerosis and the epigenetic implications. Neurodegener Dis 2011, 8:1-8.
38. Graham A.J., MacDonald A.M., Hawkes G.H. British motor neuron disease twin study. J Neurol Neurosurg Psychiatry 1997, 62:562-569.
39. Social Trends Social trends 2011 2012, HMSO, London.
40. Singh-Manoux A., Kivimaki M., Glymour M., Elbaz A., Berr C., Ebeier K, Ferrie J, Dugrarot A. Timing of cognitive decline: results from Whitehall II study. Br Med J 2012, 344:1-8.